Article thumbnail

Sequence Diversity within the Capsular Genes of Streptococcus pneumoniae Serogroup 6 and 19

By Karin Elberse, Sandra Witteveen, Han van der Heide, Ingrid van de Pol, Corrie Schot, Arie van der Ende, Guy Berbers and Leo Schouls

Abstract

The main virulence factor of Streptococcus pneumoniae is the capsule. The polysaccharides comprising this capsule are encoded by approximately 15 genes and differences in these genes result in different serotypes. The aim of this study was to investigate the sequence diversity of the capsular genes of serotypes 6A, 6B, 6C, 19A and 19F and to explore a possible effect of vaccination on variation and distribution of these serotypes in the Netherlands. The complete capsular gene locus was sequenced for 25 serogroup 6 and for 20 serogroup 19 isolates. If one or more genes varied in 10 or more base pairs from the reference sequence, it was designated as a capsular subtype. Allele-specific PCRs and specific gene sequencing of highly variable capsular genes were performed on 184 serogroup 6 and 195 serogroup 19 isolates to identify capsular subtypes. This revealed the presence of 6, 3 and a single capsular subtype within serotypes 6A, 6B and 6C, respectively. The serotype 19A and 19F isolates comprised 3 and 4 capsular subtypes, respectively. For serogroup 6, the genetic background, as determined by multi locus sequence typing (MLST) and multiple- locus variable number of tandem repeat analysis (MLVA), seemed to be closely related to the capsular subtypes, but this was less pronounced for serogroup 19 isolates. The data also suggest shifts in the occurrence of capsular subtypes within serotype 6A and 19A after introduction of the 7-valent pneumococcal vaccine. The shifts within these non-vaccine serotypes might indicate that these capsular subtypes are filling the niche of the vaccine serotypes. In conclusion, there is considerable DNA sequence variation of the capsular genes within pneumococcal serogroup 6 and 19. Such changes may result in altered polysaccharides or in strains that produce more capsular polysaccharides. Consequently, these altered capsules may be less sensitive for vaccine induced immunity

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3174988
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1998). A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease.
  2. (1999). A single gene (tts) located outside the cap locus directs the formation of Streptococcus pneumoniae type 37 capsular polysaccharide. Type 37 pneumococci are natural, genetically binary strains.
  3. (2007). Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance.
  4. (2005). Carbohydrate engineering of the recognition motifs in streptococcal co-aggregation receptor polysaccharides.
  5. (1993). Cloning and sequencing of a gene involved in the synthesis of the capsular polysaccharide of Streptococcus pneumoniae type 3.
  6. (1999). Comparative genetics of capsular polysaccharide biosynthesis in Streptococcus pneumoniae types belonging to serogroup 19.
  7. (2005). CpsE from type 2 Streptococcus pneumoniae catalyzes the reversible addition of glucose-1-phosphate to a polyprenyl phosphate acceptor, initiating type 2 capsule repeat unit formation.
  8. (2001). Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms.
  9. (2007). Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae.
  10. (2004). Evolutionary genetics of the capsular locus of serogroup 6 pneumococci.
  11. (2004). Genetic analysis of diverse disease-causing pneumococci indicates high levels of diversity within serotypes and capsule switching.
  12. (2006). Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes.
  13. (2007). Genetic basis for the new pneumococcal serotype, 6C.
  14. (2010). Identification of natural pneumococcal isolates expressing serotype 6D by genetic, biochemical and serological characterization.
  15. (2008). Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction–eight states,
  16. (1960). Laboratory diagnosis of Pneumococcus infections.
  17. (1949). Measurement of diversity.
  18. (2001). Molecular characterization of Streptococcus pneumoniae type 4, 6B, 8, and 18C capsular polysaccharide gene clusters.
  19. (1998). Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.
  20. (2011). Multiple-Locus Variable Number Tandem Repeat Analysis for Streptococcus pneumoniae:
  21. (2009). Pneumococcal capsular polysaccharide structure predicts serotype prevalence.
  22. (2010). Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains.
  23. (2011). Rapid pneumococcal evolution in response to clinical interventions.
  24. (2004). Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage.
  25. (1995). Six newly recognized types of Streptococcus pneumoniae.
  26. (2010). Streptococcus pneumoniae isolates expressing a capsule with epitopes of both serotypes 6A and 6B.
  27. (1999). Structure, assembly and regulation of expression of capsules in Escherichia coli.
  28. (1976). The quellung reaction, a neglected microbiologic technique.
  29. (1980). The structures of the cross-reactive types 19 (19F) and 57 (19A) pneumococcal capsular polysaccharides.
  30. (2005). Use of pyrosequencing to differentiate Streptococcus pneumoniae serotypes 6A and 6B.